165 related articles for article (PubMed ID: 23496909)
21. Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy.
Hua L; Wang Z; Zhao L; Mao H; Wang G; Zhang K; Liu X; Wu D; Zheng Y; Lu J; Yu R; Liu H
Theranostics; 2018; 8(18):5088-5105. PubMed ID: 30429888
[TBL] [Abstract][Full Text] [Related]
22. Enhancement radiation-induced apoptosis in C6 glioma tumor-bearing rats via pH-responsive magnetic graphene oxide nanocarrier.
Shirvalilou S; Khoei S; Khoee S; Mahdavi SR; Raoufi NJ; Motevalian M; Karimi MY
J Photochem Photobiol B; 2020 Apr; 205():111827. PubMed ID: 32120183
[TBL] [Abstract][Full Text] [Related]
23. Trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid (anti-18F-FACBC) is a feasible alternative to 11C-methyl-L-methionine and magnetic resonance imaging for monitoring treatment response in gliomas.
Sasajima T; Ono T; Shimada N; Doi Y; Oka S; Kanagawa M; Baden A; Mizoi K
Nucl Med Biol; 2013 Aug; 40(6):808-15. PubMed ID: 23701701
[TBL] [Abstract][Full Text] [Related]
24. Development of a Hypoxic Radiosensitizer-Prodrug Liposome Delivery DNA Repair Inhibitor Dbait Combination with Radiotherapy for Glioma Therapy.
Liu H; Cai Y; Zhang Y; Xie Y; Qiu H; Hua L; Liu X; Li Y; Lu J; Zhang L; Yu R
Adv Healthc Mater; 2017 Jun; 6(12):. PubMed ID: 28371526
[TBL] [Abstract][Full Text] [Related]
25. ATR kinase inhibitors NVP-BEZ235 and AZD6738 effectively penetrate the brain after systemic administration.
Fròsina G; Profumo A; Marubbi D; Marcello D; Ravetti JL; Daga A
Radiat Oncol; 2018 Apr; 13(1):76. PubMed ID: 29685176
[TBL] [Abstract][Full Text] [Related]
26. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
27. Suppression of Angiotensin-(1-7) on the Disruption of Blood-Brain Barrier in Rat of Brain Glioma.
Li X; Wang X; Xie J; Liang B; Wu J
Pathol Oncol Res; 2019 Jan; 25(1):429-435. PubMed ID: 30229380
[TBL] [Abstract][Full Text] [Related]
28. Influence of blood-brain barrier permeability on O-(2-
Stegmayr C; Bandelow U; Oliveira D; Lohmann P; Willuweit A; Filss C; Galldiks N; Lübke JH; Shah NJ; Ermert J; Langen KJ
Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):408-416. PubMed ID: 27613541
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of radiotherapy efficacy by silver nanoparticles in hypoxic glioma cells.
Liu Z; Tan H; Zhang X; Chen F; Zhou Z; Hu X; Chang S; Liu P; Zhang H
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S922-S930. PubMed ID: 30307330
[TBL] [Abstract][Full Text] [Related]
30. Relation between polyporphyrin distribution and blood brain barrier changes in the rat glioma model.
Ji Y; Walstad DL; Brown JT; Powers SK
Lasers Surg Med; 1992; 12(2):174-9. PubMed ID: 1533436
[TBL] [Abstract][Full Text] [Related]
31. Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation.
Sheehan J; Ionescu A; Pouratian N; Hamilton DK; Schlesinger D; Oskouian RJ; Sansur C
J Neurosurg; 2008 May; 108(5):972-8. PubMed ID: 18447715
[TBL] [Abstract][Full Text] [Related]
32. Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells.
Thotala D; Karvas RM; Engelbach JA; Garbow JR; Hallahan AN; DeWees TA; Laszlo A; Hallahan DE
Oncotarget; 2015 Oct; 6(33):35004-22. PubMed ID: 26413814
[TBL] [Abstract][Full Text] [Related]
33. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936
[TBL] [Abstract][Full Text] [Related]
34. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.
Morrone FB; Oliveira DL; Gamermann P; Stella J; Wofchuk S; Wink MR; Meurer L; Edelweiss MI; Lenz G; Battastini AM
BMC Cancer; 2006 Sep; 6():226. PubMed ID: 16995949
[TBL] [Abstract][Full Text] [Related]
35. Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy.
Li Y; Owusu A; Lehnert S
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):519-27. PubMed ID: 14751523
[TBL] [Abstract][Full Text] [Related]
36. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
37. Influence of Bevacizumab on Blood-Brain Barrier Permeability and
Stegmayr C; Oliveira D; Niemietz N; Willuweit A; Lohmann P; Galldiks N; Shah NJ; Ermert J; Langen KJ
J Nucl Med; 2017 May; 58(5):700-705. PubMed ID: 28153956
[TBL] [Abstract][Full Text] [Related]
38. Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.
Narayan RS; Gasol A; Slangen PLG; Cornelissen FMG; Lagerweij T; Veldman HYYE; Dik R; van den Berg J; Slotman BJ; Würdinger T; Haas-Kogan DA; Stalpers LJA; Baumert BG; Westerman BA; Theys J; Sminia P
Mol Cancer Ther; 2018 Feb; 17(2):347-354. PubMed ID: 28958992
[TBL] [Abstract][Full Text] [Related]
39. Activation of C6 glioblastoma cell ceruloplasmin expression by neighboring human brain endothelia-derived interleukins in an in vitro blood-brain barrier model system.
McCarthy RC; Kosman DJ
Cell Commun Signal; 2014 Oct; 12():65. PubMed ID: 25311416
[TBL] [Abstract][Full Text] [Related]
40. Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.
Cooper I; Last D; Guez D; Sharabi S; Elhaik Goldman S; Lubitz I; Daniels D; Salomon S; Tamar G; Tamir T; Mardor R; Fridkin M; Shechter Y; Mardor Y
J Cereb Blood Flow Metab; 2015 Jun; 35(6):967-76. PubMed ID: 25669901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
